Skip to main content
CellaVision logo

CellaVision — Investor Relations & Filings

Ticker · CEVI ISIN · SE0000683484 LEI · 529900IUBZBZ0HXFJ114 ST Manufacturing
Open in API
Filings indexed 388 across all filing types
Latest filing 2026-04-28 AGM Information
Country SE Sweden
Listing ST CEVI

About CellaVision

https://www.cellavision.com/

CellaVision is a medical technology company that provides digital solutions for cell morphology in hematology. The company specializes in automating and standardizing the analysis of blood and other body fluids for both human and veterinary applications. Its core offerings include a complete system of analyzers, instruments, software, and reagents designed for hematology laboratories of all sizes. By utilizing patented technology that integrates automated microscopy, advanced image analysis, and artificial intelligence, CellaVision's systems digitize the traditional manual review of blood smears. This automation enhances laboratory workflow efficiency, improves diagnostic accuracy, and facilitates remote collaboration among healthcare professionals, advancing diagnostic certainty.

Recent filings

Filing Released Lang Actions
Kommuniké från årsstämma i CellaVision AB (publ)
AGM Information Classification · 1% confidence The document is a press release summarizing the resolutions and decisions made at CellaVision AB’s Annual General Meeting (AGM) on 28 April 2026, including approval of financial statements, dividend distribution, board and auditor elections, and share repurchase authorisation. It is not the full annual report but an AGM communiqué. Therefore, it fits “AGM Information” (Code: AGM-R).
2026-04-28 Swedish
Bulletin from the Annual General Meeting of CellaVision AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official bulletin summarizing the resolutions passed at CellaVision’s 2026 Annual General Meeting – including adoption of financial statements, dividend approval, board elections, remuneration mandates, and share repurchase authorization. It reports the voting outcomes of shareholder resolutions, matching the profile of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-04-28 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for CellaVision covering the period January-March 2026. It contains comprehensive financial statements, including income statements, cash flow analysis, and detailed management commentary on regional performance (Americas, EMEA, APAC) and strategic progress. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2026
2026-04-24 Swedish
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive quarterly financial report for CellaVision covering the period January 1st to March 31st, 2026. It includes detailed financial statements (Net sales, EBITDA, Profit before tax, EPS, Cash flow), management commentary on performance by region (Americas, EMEA, APAC), and strategic updates. It is not an announcement of a report (RPA) or a simple earnings release (ER) as it contains substantive financial analysis and tables. Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-04-24 English
The Nomination Committee’s proposals for the 2026 Annual General Meeting of CellaVision AB
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Nomination Committee announcement of proposals for election of board members and related agenda items for the upcoming Annual General Meeting. It is sent to shareholders to provide information and solicit votes on board appointments and remuneration. This aligns with the definition of a Proxy Solicitation & Information Statement (Code: PSI), which covers materials sent to shareholders ahead of meetings to inform and request votes. Therefore, the appropriate classification is PSI.
2026-04-16 English
Valberedningens förslag inför årsstämman 2026 i CellaVision AB
Board/Management Information Classification · 1% confidence The document is a press release by CellaVision’s nomination committee outlining proposals for the 2026 Annual General Meeting regarding the number of board members, election of board members, election of the board chairman, and board fees. It announces changes in the company’s board composition rather than presenting full financials, proxy materials, or regulatory forms. This aligns with the definition of Board/Management Information (MANG).
2026-04-16 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.